Kerstin Hermelink
Kerstin Hermelink
Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich
Adresse e-mail validée de med.uni-muenchen.de
Titre
Citée par
Citée par
Année
Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study
K Hermelink, M Untch, MP Lux, R Kreienberg, T Beck, I Bauerfeind, ...
Cancer 109 (9), 1905-1913, 2007
3592007
Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study
K Hermelink, H Küchenhoff, M Untch, I Bauerfeind, MP Lux, M Bühner, ...
Psycho‐Oncology 19 (12), 1321-1328, 2010
1452010
Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study
K Hermelink, V Henschel, M Untch, I Bauerfeind, MP Lux, K Munzel
Cancer 113 (9), 2431-2439, 2008
872008
Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress
K Hermelink, V Voigt, J Kaste, F Neufeld, R Wuerstlein, M Bühner, ...
JNCI: Journal of the National Cancer Institute 107 (7), 2015
652015
Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients
K Hermelink, M Bühner, P Sckopke, F Neufeld, J Kaste, V Voigt, K Münzel, ...
JNCI: Journal of the National Cancer Institute 109 (10), 2017
602017
Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain
K Hermelink
Journal of the National Cancer Institute Monographs 2015 (51), 67-69, 2015
512015
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study
V Voigt, F Neufeld, J Kaste, M Bühner, P Sckopke, R Wuerstlein, ...
Psycho‐Oncology 26 (1), 74-80, 2017
492017
Immunotherapy: new options in breast cancer treatment
M Untch, N Ditsch, K Hermelink
Informa Healthcare 3 (3), 403-408, 2003
432003
Menopausal Status in Breast Cancer Patients with Past Chemotherapy Determines Long‐Term Hypoactive Sexual Desire Disorder
R Ochsenkühn, K Hermelink, AH Clayton, V von Schönfeldt, J Gallwas, ...
The Journal of Sexual Medicine 8 (5), 1486-1494, 2011
402011
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the …
V Amoroso, D Generali, T Buchholz, M Cristofanilli, R Pedersini, ...
JNCI Monographs 2015 (51), 90-96, 2015
312015
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer
A Vattai, E Akyol, C Kuhn, S Hofmann, H Heidegger, F von Koch, ...
Journal of cancer research and clinical oncology 143 (9), 1637-1647, 2017
192017
Reply to Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
JS Wefel, CA Meyers
Cancer 117 (5), 1103-1104, 2011
14*2011
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
A Semmlinger, V von Schoenfeldt, V Wolf, A Meuter, TM Kolben, T Kolben, ...
BMC cancer 18 (1), 1-9, 2018
122018
TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC
S Stavrou, M Gratz, E Tremmel, C Kuhn, S Hofmann, H Heidegger, ...
Endocrine connections 7 (2), 372-384, 2018
92018
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
A Vattai, V Cavailles, S Sixou, S Beyer, C Kuhn, M Peryanova, ...
Oncotarget 8 (62), 105356, 2017
82017
Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
E Tremmel, S Hofmann, C Kuhn, H Heidegger, S Heublein, K Hermelink, ...
Breast Cancer: Targets and Therapy 11, 87, 2019
52019
Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients?
K Hermelink, H Höhn, S Hasmüller, J Gallwas, K Haertl, R Wuerstlein, ...
Breast Care 9 (2), 129-129, 2014
52014
Factors associated with the decline of psychological support in hospitalized patients with cancer
T Pichler, A Dinkel, B Marten‐Mittag, K Hermelink, E Telzerow, ...
Psycho‐Oncology, 2019
32019
Listening: Reflections on a Series of Counseling Sessions
K Hermelink
Journal of Clinical Oncology 30 (5), 558-559, 2012
22012
Führt Chemotherapie zum" Chemobrain"?: Therapie des Mamma-Karzinoms und Kogntive Leistungsfähigkeit
K Münzel, K Hermelink
na, 2005
22005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20